Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cory R Trankle

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Heart Failure|January 23, 2019
Potential role for interleukin-1 in the cardio-renal syndromeLeo F Buckley, Justin M Canada, Salvatore Carbone, et al.
Journal of Cardiovascular Pharmacology|May 14, 2020
Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute PericarditisGeorge F Wohlford, Leo F Buckley, Alessandra Vecchié, et al.
Journal of Cardiovascular Pharmacology|February 16, 2022
Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial InfarctionMarco Giuseppe Del Buono, Juan Ignacio Damonte, Juan Guido Chiabrando, et al.
Minerva Cardiology and Angiology|July 14, 2020
Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMIMarco G Del Buono, Cory R Trankle, Leo Buckley, et al.
Journal of Cardiac Failure|May 16, 2019
Left Ventricular Assist Device Outflow Graft Compression: Incidence, Clinical Associations and Potential EtiologiesCory R Trankle, John D Grizzard, Keyur B Shah, et al.
Clinical Cardiology|May 6, 2017
Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2)Benjamin W Van Tassell, Leo F Buckley, Salvatore Carbone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2021
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trialsAntonio Abbate, George F Wohlford, Marco Giuseppe Del Buono, et al.
Journal of Cardiovascular Pharmacology|May 9, 2018
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical TrialsLeo F Buckley, Salvatore Carbone, Cory R Trankle, et al.
The American Journal of Cardiology|September 25, 2018
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive ProteinCory R Trankle, Justin M Canada, Laura Cei, et al.
Cardio-Oncology (London, England)|July 10, 2023
Simultaneous exercise stress cardiac magnetic resonance and cardiopulmonary exercise testing to elucidate the Fick components of aerobic exercise capacity: a feasibility and reproducibility study and pilot study in hematologic cancer survivorsJustin M Canada, John McCarty, Jennifer H Jordan, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Heart Failure|January 23, 2019
Potential role for interleukin-1 in the cardio-renal syndromeLeo F Buckley, Justin M Canada, Salvatore Carbone, et al.
Journal of Cardiovascular Pharmacology|May 14, 2020
Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute PericarditisGeorge F Wohlford, Leo F Buckley, Alessandra Vecchié, et al.
Journal of Cardiovascular Pharmacology|February 16, 2022
Effect of IL-1 Blockade With Anakinra on Heart Failure Outcomes in Patients With Anterior Versus Nonanterior ST Elevation Myocardial InfarctionMarco Giuseppe Del Buono, Juan Ignacio Damonte, Juan Guido Chiabrando, et al.
Minerva Cardiology and Angiology|July 14, 2020
Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMIMarco G Del Buono, Cory R Trankle, Leo Buckley, et al.
Journal of Cardiac Failure|May 16, 2019
Left Ventricular Assist Device Outflow Graft Compression: Incidence, Clinical Associations and Potential EtiologiesCory R Trankle, John D Grizzard, Keyur B Shah, et al.
Clinical Cardiology|May 6, 2017
Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2)Benjamin W Van Tassell, Leo F Buckley, Salvatore Carbone, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 7, 2021
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trialsAntonio Abbate, George F Wohlford, Marco Giuseppe Del Buono, et al.
Journal of Cardiovascular Pharmacology|May 9, 2018
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical TrialsLeo F Buckley, Salvatore Carbone, Cory R Trankle, et al.
The American Journal of Cardiology|September 25, 2018
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive ProteinCory R Trankle, Justin M Canada, Laura Cei, et al.
Cardio-Oncology (London, England)|July 10, 2023
Simultaneous exercise stress cardiac magnetic resonance and cardiopulmonary exercise testing to elucidate the Fick components of aerobic exercise capacity: a feasibility and reproducibility study and pilot study in hematologic cancer survivorsJustin M Canada, John McCarty, Jennifer H Jordan, et al.
Pageof 8